Finanzas de LeMaitre Vascular Inc (LMAT)LMATLeMaitre Vascular Inc

Evaluating the bottom line, LeMaitre Vascular, Inc. maintains a gross margin of 72.13%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 28.98%, while the net margin is 24.22%. These profitability ratios, combined with a Return on Equity (ROE) of 16.77%, provide a clear picture of how effectively LMAT converts its operational activities into shareholder value.

In the context of the broader market, LMAT competes directly with industry leaders such as ESTA and XRAY. With a market capitalization of $1.93B, it holds a significant position in the sector. When comparing efficiency, LMAT's gross margin of 72.13% stands against ESTA's 70.64% and XRAY's 54.90%. Such benchmarking helps identify whether LeMaitre Vascular, Inc. is trading at a premium or discount relative to its financial performance.

LeMaitre has demonstrated solid financial performance with a gross margin of 72.13% in Q2 2026 and a net income increase of 24% year-over-year, indicating strong profitability. However, the company revised its full-year revenue guidance down to $276.3 million, reflecting challenges in growth expectations.